EMBO Molecular Medicine

Submit papers now for 2009 launch!

A new EMBO journal for a new discipline.

Senior Editors Dario R. Alessi, Dundee (UK) Giulio Cossu, Milan (IT) Uta Francke, Palo Alto, (US) Fred H. Gage, San Diego (US) Matthias Hentze, Heidelberg (DE) Edison Liu (SG) Philippe Sansonetti, Paris (FR) Bart de Strooper, Leuven (BE) EMBO Molecular Medicine Editor Sandra Caldeira EMBO Associate Editor Les Grivell Editorial Assistant Gerlinde Schuster Website www.embomolmed.org  info@embomolmed.org A new journal where molecular biology meets clinical research

EMBO Molecular Medicine is a new journal from EMBO dedicated to a new research discipline where clinical research and basic biology meet.

Be one of the first to publish in EMBO Molecular Medicine:
Contact EMBO Editor Sandra Caldeira at info@embomolmed.org

Why molecular medicine?

EMBO Molecular Medicine joins EMBO Molecular Medicine Fellowships and the annual EMBO Molecular Medicine Workshop as the latest EMBO initiative aimed at strengthening links between basic biology researchers and clinicians.

The concepts and approaches of molecular biology can lead to a deeper understanding of the molecular basis of disease states. Effective translation of resulting new insights into cells and their interactions in the human body could yield novel applications for the prevention, treatment and cure of human disease.

About EMBO Molecular Medicine

EMBO Molecular Medicine publishes the results of original research in the molecular medicine field expected to be of high interest to both medical and basic scientists.

Priority articles will be those offering novel and relevant molecular insight into the cellular and systemic processes underlying defined human diseases. Readers will be interested in new perspectives for clinical application at the levels of diagnosis, prevention and therapy.

Research articles and reviews for all fields of clinical medicine and related basic biology research areas will appear in both print and online. Studies based on model organisms also are within the journal scope, provided results are evidently and directly relevant to human disease.

EMBO Molecular Medicine offers free subscription for the first two years of publication. Authors of accepted articles may pay for immediate free access on publication.

EMBO Molecular Medicine is published for EMBO by Wiley-Blackwell.